Worth Watching Stock’s Buzzers: Kinross Gold Corporation (USA) (NYSE:KGC), F D C Ltd (Parent) (NSE:FDC), Array Biopharma Inc (NASDAQ:ARRY)

On Thursday, Shares of Kinross Gold Corporation (USA) (NYSE:KGC), subtract -3.58% and closed at $3.50 in the last trading session. The last trading range of the stock ranges between $3.42 and $3.58. Kinross Gold Corporation (TSX:K.TO) (KGC) is happy to declare that it has agreed to a new three-year collective labour agreement (CLA) with unionized employees at its Tasiast mine in Mauritania.

As formerly declared in its Q2 2016 results news release, the Company and the Government of Mauritania have also agreed to a “Mauritanization” plan to increase the number of local workers at Tasiast, a requirement under Mauritanian law. Tasiast resumed normal mining and processing activities in mid-August after resolving the expatriate work permit issue, which was part of the Mauritanization plan agreement.

F D C Ltd (Parent) (NSE: FDC), dropped -0.29% and closed at $221.65 in the last trading session. The last trading range of the stock ranges between $220.00 and $224.75. The company’s Market capitalization is $39.48 Billion with the total Outstanding Shares of 177.83 Million. First Data (FDC), a global leader in commerce enabling technology and Bypass, an innovator in enterprise point-of-sale solutions, recently declared that they have teamed up to provide the Seattle Seahawks with cutting edge commerce technology at the Seahawks’ home, CenturyLink Field. With First Data’s integrated solution for Bypass, the two companies are working to revolutionize the fan experience at the stadium, starting with a full-venue deployment of hundreds of Clover point-of-sale devices.

CenturyLink Field and CenturyLink Field Event Center host more than two million people per year, all of whom want to be able to quickly purchase food and beverages so they can make it back to their seats in time for the next play or set. With Clover and Bypass, the concession buying experience becomes quick and convenient for all attendees.

David Young, CenturyLink Field GM & VP of Operations, explained the importance of modernizing their POS solution: “Improving the fan experience was a key factor for upgrading our point-of-sale systems. We want our fans to get their food and drinks quickly, so they spend more time enjoying the game and less time waiting in line.”

Array Biopharma Inc (NASDAQ:ARRY), lost -2.34% and closed at $6.68 in the last trading session. The last trading range of the stock ranges between $6.62 and $6.81. During the 52-week trading session the minimum price at which share price traded, registered at $2.38 and reached to max level of $7.27. Array BioPharma Inc. (ARRY) declared recently the closing of its underwritten public offering of 21,160,000 shares of its common stock, which includes 2,760,000 shares of common stock issued upon the exercise in full of the option to purchase additional shares granted to the underwriters, at a public offering price of $6.25 per share. The total gross proceeds from the offering are $132.25 million, before underwriting discounts and commissions and offering expenses.

J.P. Morgan Securities LLC and Cowen and Company, LLC acted as joint book-running managers for the offering.  Stifel and Wells Fargo Securities, LLC acted as lead managers and SunTrust Robinson Humphrey, Inc. acted as co-manager.

The shares were sold following an effective shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). This press release does not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

Leave a Reply

Your email address will not be published. Required fields are marked *